STAT

‘Left behind’: Drug companies and researchers have overlooked patients who don’t respond to HIV meds

Drug companies and researchers aren’t actively pursuing new treatments that would boost the immunity of HIV non-responders, the tens of thousands of people for whom drugs now don't work.

To look at Nelson Vergel, you would never guess what he has been through. For 35 years, he has kept up a relentless fight against HIV, but his muscular physique is that of a man decades younger. Regular workouts, fatty breakfasts of arepas stuffed with cheese and eggs — a staple of his native Venezuela — and 32 massive pills a day have kept him fit and driven the virus from his blood. And yet, all is not well.

Four years ago, Vergel developed and beat lymphoma. He has irritable bowel syndrome, chronic diarrhea, and severe fatigue, and in 2015, he had surgery on his right hand for a nerve disorder; he still can use only one finger on that hand to type. “Chemo was nothing compared to that,” he says.

Vergel, 59, attributes most of these conditions to his low CD4 count, a key marker of immune function in HIV-positive people. He is what’s known as an immunologic non-responder (INR) —

You're reading a preview, sign up to read more.

More from STAT

STAT1 min readSociety
Listen: A J.P. Morgan Recap, A Plan To Bust Pharma Monopolies, And A Website For Cancer Patients
Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find? Find out on the latest…
STAT4 min readSociety
‘How Long Do I Have?’ A Website On Cancer Survival Rates, From The Co-founder Of GoodRx, Seeks To Provide Clarity
A new online tool from the co-founder of GoodRx seeks to answer a simple but daunting question for cancer patients: "How long do I have?"
STAT4 min readSociety
Opinion: Why Black Doctors Like Me Are Leaving Faculty Positions In Academic Medical Centers
It's ironic that Black faculty members are unfairly tasked with the complex and overwhelming chore of remedying the structural outcomes of centuries of institutionalized racism in medicine that they did…